P. major seems to be effective in complementary management of ulcerative colitis. - GreenMedInfo Summary
Efficacy of Plantago major seed in management of ulcerative colitis symptoms: A randomized, placebo controlled, clinical trial.
Complement Ther Clin Pract. 2021 Aug ;44:101444. Epub 2021 Jul 10. PMID: 34265576
Atiyeh Baghizadeh
OBJECTIVE: Evaluation of the effect of Plantago major (P. major) seed on ulcerative colitis (UC) symptoms.
METHODS: In this randomized double-blind clinical trial, 61 subjects received 3600 mg/day roasted P. major seed in intervention group (n = 31) and roasted wheat flour in control group (n = 30), for 8 weeks, as a complementary to standard medications. Variables were assessed using the Lichtiger Colitis Activity Index (LCAI) at baseline, week 4, and week 8.
RESULTS: 51 patients completed the trial (n = 28 in Plantago and n = 23 in placebo groups). Abdominal tenderness (p = 0.011), gastroesophageal reflux and gastric pain (p = 0.049 for both), were significantly less severe in P. major group. Visible blood in stool (p = 0.001), distension (p = 0.001), and anal pain (p = 0.051), decreased significantly in P. major group, although no significant difference was observed between the two groups: (p = 0.224), (p = 0.283), and (p = 0.455) respectively.
CONCLUSION: P. major seems to be effective in complementary management of UC.